Moreover, the endothelial cells in the tumor microenvironment promote FasL and inhibitory molecules expression (such as PD-L1, TIM3, IDO-1, PGE2, and IL-10) which subsequently suppressed effector T cell activity [34, 35]. The gene discussed is CD274; the disease is neoplasm.